Marinus Pharmaceuticals investor relations material

Listen to the latest call from Marinus Pharmaceuticals

Marinus Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing and commercializing therapeutics to treat epilepsy with a focus on rare and orphan seizures, as well as neuropsychiatric disorders in the United States.

  • Ticker

    MRNS
  • Country

    US

Dig deeper into the Marinus Pharmaceuticals fundamentals on Quartr.